CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2 enrolled
Drug / intervention
PET/CT Imagingradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01985971
NCT01985971N/ACompleted
CompareCT.gov

F18 EF5 PET/CT Imaging in Patients With Brain Metastases From Breast Cancer

Abramson Cancer Center at Penn Medicine·interventional·Posted Nov 18, 2013·Updated Jan 31, 2020

In Brief

A clinical study evaluating PET/CT Imaging for Brain Metastases From Breast Cancer. Completed, enrolled 2 participants across 1 site.

Detailed Summary

To estimate the presence of hypoxia in individual lesions after radiotherapy in patients with brain metastases from breast cancer as identified by F18 EF5 PET/CT imaging.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBrain Metastases From Breast Cancer
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedNov 18, 2013
Enrollment StartMar 1, 2011
Primary CompletionAug 19, 2016
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 12.6 years ago

Interventions

PET/CT Imagingradiation